Praluent and Bumetanide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Praluent (alirocumab) and Bumetanide (bumetanide). Common drug interactions include blood glucose increased among females and headache among males.

The phase IV clinical study analyzes what interactions people have when they take Praluent and Bumetanide. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Praluent?

Praluent has active ingredients of alirocumab. It is often used in high blood cholesterol. eHealthMe is studying from 24,963 Praluent users. Check the latest studies of Praluent.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.



On Jul, 29, 2026

34 people who take Praluent and Bumetanide together, and have interactions are studied.

Praluent and Bumetanide drug interactions.

What are the common drug interactions of Praluent and Bumetanide, by gender? *:

female:

  1. Blood glucose increased
  2. Contusion (a type of hematoma of tissue in which capillaries)
  3. Cough
  4. Death
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Muscle spasms (muscle contraction)
  7. Nausea (feeling of having an urge to vomit)
  8. Night sweats (sweating in night)
  9. Rash
  10. Therapeutic response decreased (less preventive response)

male:

  1. Headache (pain in head)
  2. Therapeutic response unexpected
  3. Haemorrhage (bleeding)
  4. Injection site reaction
  5. Memory impairment
  6. Myalgia (muscle pain)
  7. Pain in extremity
  8. Sleep disorder
  9. Ulcer
  10. Ammonia increased

What are the common drug interactions of Praluent and Bumetanide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Blood glucose increased
  2. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  3. Eye disorder
  4. Heart rate irregular
  5. Influenza
  6. Pruritus (severe itching of the skin)
  7. Pruritus generalised (generalized itching)

60+:

  1. Death
  2. Headache (pain in head)
  3. Rash
  4. Sleep disorder
  5. Therapeutic response decreased (less preventive response)
  6. Urinary tract disorder
  7. Drug resistance (reduction in effectiveness of a drug)
  8. Low density lipoprotein increased (cholesterol increased in blood)
  9. Ammonia increased
  10. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)

What are the existing conditions these people have? *

  1. Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 11.76%
  2. Stress And Anxiety: 2 people, 5.88%
  3. Indigestion: 2 people, 5.88%
  4. Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Praluent and Bumetanide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Praluent and Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Praluent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Praluent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bumetanide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on alirocumab and bumetanide (the active ingredients of Praluent and Bumetanide, respectively), and Praluent and Bumetanide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: